These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27536664)

  • 1. Genetics and Epigenetics of Diabetic Nephropathy.
    Liu R; Lee K; He JC
    Kidney Dis (Basel); 2015 May; 1(1):42-51. PubMed ID: 27536664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modifications in the pathogenesis of diabetic nephropathy.
    Reddy MA; Tak Park J; Natarajan R
    Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Regulations in Diabetic Nephropathy.
    Lu Z; Liu N; Wang F
    J Diabetes Res; 2017; 2017():7805058. PubMed ID: 28401169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications and diabetic nephropathy.
    Reddy MA; Park JT; Natarajan R
    Kidney Res Clin Pract; 2012 Sep; 31(3):139-50. PubMed ID: 26894019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and Management of Diabetic Nephropathy in Asia.
    Tomino Y; Gohda T
    Kidney Dis (Basel); 2015 May; 1(1):52-60. PubMed ID: 27536665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Susceptibility Genes in Diabetic Nephropathy.
    Wei L; Xiao Y; Li L; Xiong X; Han Y; Zhu X; Sun L
    Kidney Dis (Basel); 2018 Nov; 4(4):226-237. PubMed ID: 30574499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting epigenetic regulators for treating diabetic nephropathy.
    Kushwaha K; Garg SS; Gupta J
    Biochimie; 2022 Nov; 202():146-158. PubMed ID: 35985560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics and Inflammation in Diabetic Nephropathy.
    Shao BY; Zhang SF; Li HD; Meng XM; Chen HY
    Front Physiol; 2021; 12():649587. PubMed ID: 34025445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy--emerging epigenetic mechanisms.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2014 Sep; 10(9):517-30. PubMed ID: 25003613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways.
    Nazir N; Siddiqui K; Al-Qasim S; Al-Naqeb D
    BMC Med Genet; 2014 Oct; 15():103. PubMed ID: 25280384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances of genetics in diabetic nephropathy].
    Li JY; Tan YZ; Feng GY; He L; Zhou LG; Lu H
    Yi Chuan; 2012 Dec; 34(12):1537-44. PubMed ID: 23262100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human genetics of diabetic nephropathy.
    Tang ZH; Zeng F; Zhang XZ
    Ren Fail; 2015 Apr; 37(3):363-71. PubMed ID: 25594612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.
    Fan C; Gao Y; Sun Y
    Front Endocrinol (Lausanne); 2023; 14():1191768. PubMed ID: 37492198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family-based strategy to identify genes for diabetic nephropathy.
    Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
    Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
    Lu HC; Dai WN; He LY
    Diabetes Metab Syndr Obes; 2021; 14():329-344. PubMed ID: 33519221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
    Campion CG; Sanchez-Ferras O; Batchu SN
    Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential.
    Yang Y; Zeng C; Yang K; Xu S; Zhang Z; Cai Q; He C; Zhang W; Liu SM
    Extracell Vesicles Circ Nucl Acids; 2022; 3(1):49-60. PubMed ID: 35342902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
    Zhou H; Ni WJ; Meng XM; Tang LQ
    Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.